Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mexiletine - Lupin

Next Previous
Drug Profile

Mexiletine - Lupin

Alternative Names: Mexiletine hydrochloride - Lupin; Namuscla

Latest Information Update: 06 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Temmler Pharma
  • Developer Lupin
  • Class Class Ib antiarrhythmics; Local anaesthetics; Phenyl ethers; Propylamines; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Musculoskeletal disorders
  • New Molecular Entity No

Highest Development Phases

  • Marketed Musculoskeletal disorders
  • Phase III Myotonic dystrophy

Most Recent Events

  • 01 Oct 2025 Phase-III clinical trials in Myotonic dystrophy in Belgium (PO, Capsule) (NCT07097701)
  • 01 Oct 2025 Phase-III clinical trials in Myotonic dystrophy in Belgium (PO, Powder) (NCT07097701)
  • 30 Jul 2025 Lupin plans a phase III ACHILLES trial for Non-Dystrophic Myotonias (In adolescents, In adults, In the elderly) in July 2025 (PO, capsule) (PO, powder) (NCT07097701)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top